S. Traina

发表

Impact of Canagliflozin Treatment on Health-Related Quality of Life among People with Type 2 Diabetes Mellitus: A Pooled Analysis of Patient-Reported Outcomes from Randomized Controlled Trials

L. Delahanty, Jennifer Cai, S. Akapame, 2018, The Patient - Patient-Centered Outcomes Research.

The Efficacy of Omega–3 Fatty Acids on Cognitive Function in Aging and Dementia: A Systematic Review

W. Mojica, S. Morton, A. Issa, 2006, Dementia and Geriatric Cognitive Disorders.

Use of a dummy (pacifier) during sleep and risk of sudden infant death syndrome (SIDS): population based case-control study

R. Burger, H. Hoffman, W. Mojica, 2005, BMJ : British Medical Journal.

The Impact of Weight Loss on Weight-related Quality of Life and Health Satisfaction: Results From a Trial Comparing Canagliflozin With Sitagliptin in Triple Therapy Among People With Type 2 Diabetes

R. Guthrie, A. Slee, S. Traina, 2014, Postgraduate medicine.

Effects of Omega-3 Fatty Acids on Cancer Risk

W. Mojica, S. Morton, A. Issa, 2006 .

An Indirect Comparison of Changes in the Impact of Weight on Quality of Life Among Subjects with Type 2 Diabetes Treated with Antihyperglycemic Agents in Dual Therapy with Metformin

A. Slee, S. Traina, J. Diels, 2017, Diabetes Therapy.

Relationship between patient-reported outcomes and clinical outcomes in metastatic castration-resistant prostate cancer: post hoc analysis of COU-AA-301 and COU-AA-302

D. Cella, S. Traina, N. Shore, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

CANadian CAnagliflozin REgistry: Patient-Reported Outcomes of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in Canadian Clinical Practice.

V. Woo, A. Bell, M. Clement, 2019, Canadian journal of diabetes.

Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study

Nibedita Bandyopadhyay, Martin Dreyling, Mathias Witzens-Harig, 2016, The Lancet.

Effects of omega-3 fatty acids on cancer.

P. Shekelle, W. Mojica, S. Morton, 2005, Evidence report/technology assessment.

Effects of omega-3 fatty acids on cognitive function with aging, dementia, and neurological diseases.

P. Shekelle, W. Mojica, S. Morton, 2005, Evidence report/technology assessment.

Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S.

David Cella, D. Cella, E. Elkin, 2008, Supportive Care in Cancer.

Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in the HELIOS study

A. Chanan-Khan, A. Howes, N. Sengupta, 2018, Leukemia & lymphoma.

Measuring process of arthritis care: the Arthritis Foundation's quality indicator set for rheumatoid arthritis.

D. Khanna, J. Pencharz, S. Traina, 2006, Seminars in arthritis and rheumatism.

The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes

H. Rodbard, A. Peters, A. Slee, 2016, Diabetes Care.

CANadian CAnagliflozin REgistry: Effectiveness and safety of canagliflozin in the treatment of type 2 diabetes mellitus in Canadian clinical practice

V. Woo, A. Bell, M. Clement, 2018, Diabetes, obesity & metabolism.

A call to action to inform patient‐centred approaches to obesity management: Development of a disease‐illness model

K. Fujioka, R. Kolotkin, W. Canovatchel, 2019, Clinical obesity.

Cost-Effectiveness of Canagliflozin Added to Standard of Care for Treating Diabetic Kidney Disease (DKD) in Patients with Type 2 Diabetes Mellitus (T2DM) in England: Estimates Using the CREDEM-DKD Model

A. Nilsson, M. Willis, S. Traina, 2020, Diabetes Therapy.

The Complexity of Care for Patients with Rheumatoid Arthritis: Metrics for Better Understanding Chronic Disease Care

K. Kahn, L. Rubenstein, H. Paulus, 2007, Medical care.

Is There A Relationship Between Patient-Reported Outcomes (Pros) And Clinical Outcomes In Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Post-Docetaxel?

D. Cella, S. Traina, A. Molina, 2015, Value in Health.

Analysis of the Relationship Between Patient-Reported Outcomes (Pros) and Clinical Outcomes In Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Patients without Prior Chemotherapy.

D. Cella, S. Traina, A. Molina, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

The Diabetes Intention, Attitude, and Behavior Questionnaire: evaluation of a brief questionnaire to measure physical activity, dietary control, maintenance of a healthy weight, and psychological antecedents

C. Abraham, R. Crosby, S. Traina, 2016, Patient preference and adherence.

Application of explicit process of care measurement to rheumatoid arthritis: Moving from evidence to practice.

B S Mittman, K. Kahn, L. Rubenstein, 2006, Arthritis and rheumatism.

J. Goldberg, M. Jerkeman, M. Dreyling, 2017, Leukemia & lymphoma.

Rapid and sustained improvement in health-related quality of life and utility for 72 weeks in patients with ankylosing spondylitis receiving etanercept.

A. Boonen, A. Maetzel, S. Traina, 2008, The Journal of rheumatology.

Effects of omega-3 fatty acids on cancer risk: a systematic review.

W. Mojica, S. Morton, A. Issa, 2006, JAMA.

Analysis of the temporal relationship between patient-reported outcomes (PROs) and overall survival (OS) and radiographic progression-free survival (rPFS) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts).

D. Cella, S. Traina, A. Molina, 2016 .

Telephone reminder calls increased response rates to mailed study consent forms.

K. Kahn, S. Traina, C. MacLean, 2005, Journal of clinical epidemiology.

Effects of omega-3 fatty acids on cancer risk: a systematic review.

W. Mojica, S. Morton, A. Issa, 2006, JAMA.

Pragmatic measurement of health satisfaction in people with type 2 diabetes mellitus using the Current Health Satisfaction Questionnaire

R. Crosby, S. Traina, S. Mathias, 2015, Patient Related Outcome Measures.

R. Crosby, S. Traina, S. Mathias, 2022 .

Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study

J. Goldberg, M. Jerkeman, M. Dreyling, 2016, The Lancet.

Assessment of American College of Rheumatology quality criteria for rheumatoid arthritis in a pre-quality criteria patient cohort.

S. Traina, A. L. Wong, Bevra H. Hahn, 2007, Arthritis and rheumatism.

The Importance of Weight Change Experiences for Performance of Diabetes Self-Care: A Patient-Centered Approach to Evaluating Clinical Outcomes in Type 2 Diabetes

W. Canovatchel, A. Slee, S. Traina, 2015, Diabetes Therapy.

C. Abraham, R. Crosby, S. Traina, 2016, Patient preference and adherence.